Drug · DIN 02416492
NIKKI
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 21, 2014.
- Drug Identification Number (DIN)
- 02416492
- Company (DIN owner)
- Lupin LimitedMumbai, Maharashtra, India
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Drospirenone and estrogen G03AA12
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DROSPIRENONE | 3.0 MG | |
| ETHINYL ESTRADIOL | 0.02 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2014: NOC 15730Abbreviated New Drug Submission (ANDS)